Neurogene Inc (NGNE) is a biotechnology company listed on US.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
Use this NGNE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NGNE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NGNE SEC filings page. Lician reads the product cache first so this HTML stays unique to Neurogene Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NGNE income, balance, and cash tables.